Valuation Astellas Pharma Inc. OTC Markets

Stocks

ALPMY

US04623U1025

Pharmaceuticals

Market Closed - OTC Markets 01:20:47 12/09/2026 am IST			5-day change	1st Jan Change
14.56 ^USD	+2.39%		-3.26%	+9.56%

01/09	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
01/09	White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies	MT

Company Valuation: Astellas Pharma Inc.

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	35,19,738	33,81,409	29,46,773	25,89,390	45,12,563	40,17,247	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-10.98%	-	-
Enterprise Value (EV) ¹	32,03,752	30,04,569	26,11,086	32,32,444	47,96,910	39,58,069	35,36,593	31,61,305
Change	-	-6.22%	-13.1%	23.8%	48.4%	-17.49%	-10.65%	-10.61%
P/E	28.5x	34.7x	173x	51x	15.5x	10.7x	11.2x	14.6x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	1.92x	1.76x	1.67x
PEG	-	-1.8x	-2.1x	0x	0x	0.4x	-2.21x	-0.6x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.72x	1.84x	2.07x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.69x	1.62x	1.63x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.34x	5.22x	5.52x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.07x	7.67x	8.45x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	8.72x	6.7x	6.44x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	11.5%	14.9%	15.5%
Dividend per Share ²	50	60	70	74	78	80.15	83.08	85.31
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.58%	3.71%	3.81%
EPS ²	67.08	54.24	9.51	28.35	162.8	210.2	199.5	153.3
Distribution rate	74.5%	111%	736%	261%	47.9%	38.1%	41.6%	55.7%
Net sales ¹	12,96,163	15,18,619	16,03,672	19,12,323	21,39,245	23,38,001	21,79,962	19,38,212
EBITDA ¹	2,35,370	2,38,767	1,83,358	2,40,171	5,77,227	7,40,737	6,77,049	5,72,836
EBIT ¹	1,55,686	1,33,029	25,518	41,039	3,82,633	4,90,615	4,61,200	3,74,166
Net income ¹	1,24,086	98,714	17,045	50,747	2,91,535	3,61,063	3,39,702	2,56,881
Net Debt ¹	-3,15,986	-3,76,840	-3,35,687	6,43,054	2,84,347	-59,179	-4,80,654	-8,55,942
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,240.50	2,240.50	2,240.50
Nbr of stocks (in thousands)	18,41,831	17,95,756	17,92,986	17,90,107	17,91,411	17,93,014	-	-
Announcement Date	27/04/22	27/04/23	25/04/24	25/04/25	27/04/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	99TCr
JOHNSON & JOHNSON	29.54x	-	-	2.02%	64TCr
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	45TCr
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	34TCr
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	26TCr
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	25TCr
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	20TCr
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	19TCr
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	18TCr
Average	16.16x	6.27x	15.06x	2.51%	38.94TCr
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%